Carrera Capital Advisors Purchases New Position in The Clorox Company (NYSE:CLX)

Carrera Capital Advisors purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 17,570 shares of the company's stock, valued at approximately $2,854,000.

Other institutional investors have also recently bought and sold shares of the company. State Street Corp grew its position in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC grew its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC grew its position in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after buying an additional 33,970 shares in the last quarter. Stifel Financial Corp grew its position in Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after buying an additional 37,967 shares in the last quarter. Finally, FMR LLC grew its position in Clorox by 27.6% during the third quarter. FMR LLC now owns 776,232 shares of the company's stock worth $126,456,000 after buying an additional 168,111 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Stock Performance

Clorox stock traded up $2.74 during mid-day trading on Friday, reaching $151.11. The company's stock had a trading volume of 3,211,445 shares, compared to its average volume of 1,468,197. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a market capitalization of $18.61 billion, a P/E ratio of 41.29, a PEG ratio of 2.62 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm's fifty day moving average price is $155.65 and its two-hundred day moving average price is $160.34.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company posted $2.16 earnings per share. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.23%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the subject of several recent analyst reports. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. upped their target price on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Evercore ISI upped their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company upped their target price on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.